Market Overview

Benzinga's Top Downgrades

Share:
Benzinga's Top Downgrades

Analysts at Deutsche Bank downgraded BRE Properties (NYSE: BRE) from “buy” to “hold.” The target price for BRE Properties is set to $57. BRE Properties' shares closed at $54.11 yesterday.

Analysts at UBS downgraded TIBCO Software (NASDAQ: TIBX) from “buy” to “neutral.” TIBCO Software's shares closed at $24.48 yesterday.

Wells Fargo downgraded IAC/InterActiveCorp (NASDAQ: IACI) from “outperform” to “market perform.” The target price range for IAC/InterActiveCorp has been raised from $53-$56 to $74-$77. IAC/InterActiveCorp's shares closed at $68.49 yesterday.

Bryan Garnier & Cie downgraded Astrazeneca PLC (NYSE: AZN) from “buy” to “neutral.” Astrazeneca's shares closed at $58.90 yesterday.

Latest Ratings for BRE

DateFirmActionFromTo
Dec 2013DowngradesBuyHold
Dec 2013UpgradesUnderperformMarket Perform
Sep 2013DowngradesNeutralSell

View More Analyst Ratings for BRE
View the Latest Analyst Ratings

Posted-In: Top DowngradesDowngrades Analyst Ratings

 

Related Articles (AZN + BRE)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
VIACJP MorganReinstates50.0
NUVASVB LeerinkMaintains92.0
SRPTCantor FitzgeraldMaintains211.0
SRPTPiperJaffrayMaintains210.0
LULUGoldman SachsMaintains219.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

UPDATE: Compass Point Initiates Coverage on NMI as Top Pick in Sector

UPDATE: Compass Point Initiates Coverage on Essent as Growth Outlook Remains Bright, but Valuation is Reflective